Treatment of high tumor mutation burden metastatic extramammary Paget disease with an anti– PD ‐1 antibody
The Journal of Dermatology · 2023
DOI: 10.1111/1346-8138.16898 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Dermatology, 2023. Verfasst von Yuichi Nakayama und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Paget Disease, Extramammary, Skin Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: National Cancer Center Research and Development Fund (2023-J-03).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
ORCID-Profile: Yuichi Nakayama, Dai Ogata, Shogo Wada, Kojiro Hiki, Kenjiro Namikawa, Naoya Yamazaki
Förderung
- National Cancer Center Research and Development Fund (2023-J-03)
Zitieren
APA
Nakayama, Y., Ogata, D., Wada, S., Tsuruta, S., Matsui, Y., Okumura, M., Hiki, K., Nakano, E., Namikawa, K., & Yamazaki, N. (2023). Treatment of high tumor mutation burden metastatic extramammary Paget disease with an anti– PD ‐1 antibody. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.16898
Vancouver
Nakayama Y, Ogata D, Wada S, Tsuruta S, Matsui Y, Okumura M, et al. Treatment of high tumor mutation burden metastatic extramammary Paget disease with an anti– PD ‐1 antibody. The Journal of Dermatology. 2023. doi:10.1111/1346-8138.16898
BibTeX
@article{Nakayama2023,
author = {Nakayama, Yuichi and Ogata, Dai and Wada, Shogo and Tsuruta, Seiji and Matsui, Yoshiyuki and Okumura, Mao and Hiki, Kojiro and Nakano, Eiji and Namikawa, Kenjiro and Yamazaki, Naoya},
title = {Treatment of high tumor mutation burden metastatic extramammary Paget disease with an anti– PD ‐1 antibody},
journal = {The Journal of Dermatology},
year = {2023},
doi = {10.1111/1346-8138.16898}
}
EUVIMED